Coadjuvant treatment of botulinum toxin in bruxism

Authors

DOI:

https://doi.org/10.33448/rsd-v12i8.42852

Keywords:

Bruxism; Botulinum Toxins, Type A; Complementary therapies.

Abstract

Orofacial harmonization plays a key role in addressing functional changes in the face and mouth, aiming to restore functionality and biomechanical balance to improve the patient's quality of life. In addition to treating aesthetic problems, orofacial harmonization brings functional benefits to the masticatory, respiratory and vocal systems. On the other hand, bruxism, characterized by grinding or clenching of the teeth, can lead to serious consequences for the oral and general health of the individual, such as intense pain and wear on the teeth. Botulinum toxin has been widely used as an adjuvant treatment in these cases, relaxing the masticatory muscles, especially the masseter, providing pain relief. The safe and effective application of botulinum toxin in this context is paramount and, in this sense, the expertise in orofacial harmonization stands out by providing a personalized approach for each patient, making this combination a promising and minimally invasive option in the treatment of bruxism and its negative effects. . Thus, the objective of this narrative review of the literature is to comprehensively analyze the scientific evidence available on the use of botulinum toxin as an adjuvant treatment in bruxism.

References

Ågren, M., Sahin, C., & Pettersson, M. (2020). The effect of botulinum toxin injections on bruxism: A systematic review. Journal of oral rehabilitation, 47(3), 395–402.

Anandan, C., & Jankovic, J. (2021). Botulinum Toxin in Movement Disorders: An Update. Toxins, 13(1), 42.

Beddis, H., Pemberton, M., & Davies, S. (2018). Sleep bruxism: an overview for clinicians. British dental journal, 225(6), 497–501.

Bellows, S., & Jankovic, J. (2019). Immunogenicity Associated with Botulinum Toxin Treatment. Toxins, 11(9), 491.

Bulanda, S., Ilczuk-Rypuła, D., Nitecka-Buchta, A., Nowak, Z., Baron, S., & Postek-Stefańska, L. (2021). Sleep Bruxism in Children: Etiology, Diagnosis, and Treatment-A Literature Review. International journal of environmental research and public health, 18(18), 9544.

Choudhury, S., Baker, M. R., Chatterjee, S., & Kumar, H. (2021). Botulinum Toxin: An Update on Pharmacology and Newer Products in Development. Toxins, 13(1), 58.

Fernández-Núñez, T., Amghar-Maach, S., & Gay-Escoda, C. (2019). Efficacy of botulinum toxin in the treatment of bruxism: Systematic review. Medicina oral, patologia oral y cirugia bucal, 24(4), e416–e424.

Hardy, R. S., & Bonsor, S. J. (2021). The efficacy of occlusal splints in the treatment of bruxism: A systematic review. Journal of dentistry, 108, 103621.

Hosgor, H., & Altindis, S. (2020). Efficacy of botulinum toxin in the management of temporomandibular myofascial pain and sleep bruxism. Journal of the Korean Association of Oral and Maxillofacial Surgeons, 46(5), 335–340.

Kwon, K. H., Shin, K. S., Yeon, S. H., & Kwon, D. G. (2019). Application of botulinum toxin in maxillofacial field: part I. Bruxism and square jaw. Maxillofacial plastic and reconstructive surgery, 41(1), 38.

Lobbezoo, F., Ahlberg, J., Raphael, K. G., Wetselaar, P., Glaros, A. G., Kato, T., Santiago, V., Winocur, E., De Laat, A., De Leeuw, R., Koyano, K., Lavigne, G. J., Svensson, P., & Manfredini, D. (2018). International consensus on the assessment of bruxism: Report of a work in progress. Journal of oral rehabilitation, 45(11), 837–844.

Martins, M. G. B., Lima, N. S., Araujo, L. K. O., Lucena, M. R., Araújo, I. A. de O., Ribeiro, D. S. S., Vieira, É. C. da C., Silva, S. de J., Steinhauser, H. C., & Carvalho, R. F. (2022). Bruxismo do sono em pacientes odontopediátricos: uma revisão integrativa. Research, Society and Development, 11(14), e462111436722.

Ondo, W. G., Simmons, J. H., Shahid, M. H., Hashem, V., Hunter, C., & Jankovic, J. (2018). Onabotulinum toxin-A injections for sleep bruxism: A double-blind, placebo-controlled study. Neurology, 90(7), e559–e564.

Rother, E. T. (2007). Revisão sistemática x revisão narrativa. Acta Paul. Enferm, 20(2).

Sendra, L. A., Montez, C., Vianna, K. C., & Barboza, E. P. (2021). Clinical outcomes of botulinum toxin type A injections in the management of primary bruxism in adults: A systematic review. The Journal of prosthetic dentistry, 126(1), 33–40.

Serrera-Figallo, M. A., Ruiz-de-León-Hernández, G., Torres-Lagares, D., Castro-Araya, A., Torres-Ferrerosa, O., Hernández-Pacheco, E., & Gutierrez-Perez, J. L. (2020). Use of Botulinum Toxin in Orofacial Clinical Practice. Toxins, 12(2), 112.

Shim, Y. J., Lee, H. J., Park, K. J., Kim, H. T., Hong, I. H., & Kim, S. T. (2020). Botulinum Toxin Therapy for Managing Sleep Bruxism: A Randomized and Placebo-Controlled Trial. Toxins, 12(3), 168.

Solish, N., Carruthers, J., Kaufman, J., Rubio, R. G., Gross, T. M., & Gallagher, C. J. (2021). Overview of DaxibotulinumtoxinA for Injection: A Novel Formulation of Botulinum Toxin Type A. Drugs, 81(18), 2091–2101.

Sumodjo, P. R. P. A., Suguhihara, R. T., & Muknicka, D. P. (2023). O envelhecimento facial e a harmonização orofacial – uma revisão narrativa da literatura. Research, Society and Development, 12(5), e15312541591.

Tsetlin V. I. (2020). Acetylcholine and Acetylcholine Receptors: Textbook Knowledge and New Data. Biomolecules, 10(6), 852.

Vavrina, J., & Vavrina, J. (2020). Bruxismus: Einteilung, Diagnostik und Behandlung [Bruxism: Classification, Diagnostics and Treatment]. Praxis, 109(12), 973–978.

Published

06/08/2023

How to Cite

VIEIRA, A. A. de P. .; SUGUIHARA, R. T. .; MUKNICKA, D. P. . Coadjuvant treatment of botulinum toxin in bruxism. Research, Society and Development, [S. l.], v. 12, n. 8, p. e1512842852, 2023. DOI: 10.33448/rsd-v12i8.42852. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/42852. Acesso em: 21 may. 2024.

Issue

Section

Health Sciences